FGP
HUM icon

Foyston, Gordon, & Payne’s Humana HUM Stock Holding History

Foyston, Gordon, & Payne’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,730
Closed -$5.83M – 60
2023
Q4 		$5.83M Sell
12,730
-1,197
-9% -$590K 1.46% 25
2023
Q3 		$6.78M Buy
13,927
+4,204
+43% +$1.98M 1.85% 22
2023
Q2 		$4.35M Buy
9,723
+607
+7% +$306K 1.14% 34
2023
Q1 		$4.43M Sell
9,116
-137
-1% -$67.7K 1.19% 37
2022
Q4 		$4.74M Buy
9,253
+4,267
+86% +$2.24M 1.31% 35
2022
Q3 		$2.42M Buy
4,986
+75
+2% +$36.5K 0.66% 46
2022
Q2 		$2.3M Buy
4,911
+170
+4% +$75.6K 0.66% 44
2022
Q1 		$2.06M Buy
+4,741
New +$1.98M 0.51% 49

Other funds holding HUM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Foyston, Gordon, & Payne's HUM Position: Q1 2024 in Review

Foyston, Gordon, & Payne sold out of Humana (HUM) in Q1 2024, closing a stake of 12,730 shares — an estimated $5.83M sold.

Foyston, Gordon, & Payne first reported a position in HUM in Q1 2022 and held it in 8 quarters. The position peaked at $6.78M in Q3 2023. 1,030 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Foyston, Gordon, & Payne reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 12,730 Humana shares in Q1 2024, an estimated $5.83M.
  • Foyston, Gordon, & Payne first reported a position in Humana in Q1 2022 and held it in 8 quarters.
  • Foyston, Gordon, & Payne's Humana position peaked at $6.78M in Q3 2023.
  • 1,030 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2024, filed 7 May 2024.